TrendingWallStreet.com Begins Trend Analysis on ANR, VTUS, NVLX, and SCRC


Follow this company

Companies Mentioned

NYSE:ANR / NASDAQ:VTUS / PK:NVLX / OTC:BB:SCRC
02/13/2014 [ACCESSWIRE]

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.bulltrends.com/ to get full access to our free stock reports.

Alpha Natural Resources, Inc. (NYSE: ANR) shares closed down a modest 3.80 percent on Wednesday with about 22 million shares traded. The stock was one of the most active stocks on the NYSE after reporting a mixed earnings report. Alpha Natural reported a fourth-quarter loss of 52 cents a share. Analysts surveyed by Capital IQ expected a loss of 62 cents a share. Revenue fell 29.8% in the quarter to $1.09 billion; analysts were expecting revenue of $1.17 billion. The quarter included a $205.1 million tax charge and a $7.4 million loss on early debt extinguishment. The company also saw income tax expense rise to $92.5 million from $26.8 million.

Get more information on Alpha Natural Resources, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ANR

Ventrus Biosciences Inc. (NASDAQ: VTUS) shares closed down about 63 percent on Wednesday making Ventrus one of the biggest decliners in the NASDAQ. The stock had one of the biggest volume advances with roughly 18 million shares traded. The company announced top line efficacy and safety results from the second Phase 3 clinical trial of Diltiazem Hydrochloride 2% Cream, or VEN 307 in patients with pain related to anal fissure. VEN 307 efficacy was as expected; placebo effect greater than anticipated, resulting in no significant difference between treatments.

Get more information on Ventrus Biosciences Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/VTUS

Nuvilex, Inc. (OTC: NVLX) shares closed up 6.87 percent on Wednesday with about 4.3 million shares traded. The stock was one of the biggest gainers in the OTC market. Last year the company landed a leading figure in the medical marijuana field in Dr. Mark L. Rabe. Dr. Rabe was appointed as the Chairman of the Scientific Advisory Board of Medical Marijuana Sciences (MMS), the wholly-owned subsidiary Nuvilex formed to house its work in the Cannabis industry.

Get more information on Nuvilex, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/NVLX

ScripsAmerica, Inc. (OTCBB: SCRC) shares closed up 13.90 percent on Wednesday with about 480,000 shares traded. The stock was one of the biggest advancers in the OTCBB marketplace. The company announced that during the month of January, the Company's equity venture, Wholesale Rx "WRx," received and processed $268,696 in orders, setting a second consecutive monthly revenue record.

Get more information on ScripsAmerica, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/SCRC

 

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *